Canada markets open in 9 hours 6 minutes

Janux Therapeutics, Inc. (JANX)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
15.76-0.18 (-1.13%)
At close: 04:00PM EST
Currency in USD

Valuation Measures4

Market Cap (intraday) 820.16M
Enterprise Value 432.89M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)401.53
Price/Book (mrq)2.18
Enterprise Value/Revenue 214.20
Enterprise Value/EBITDA -20.76

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3-37.34%
S&P500 52-Week Change 322.74%
52 Week High 337.99
52 Week Low 314.39
50-Day Moving Average 319.55
200-Day Moving Average 324.20

Share Statistics

Avg Vol (3 month) 3107.23k
Avg Vol (10 day) 395.04k
Shares Outstanding 541.61M
Implied Shares Outstanding 6N/A
Float 814.06M
% Held by Insiders 111.00%
% Held by Institutions 183.11%
Shares Short (Dec. 30, 2021) 42.57M
Short Ratio (Dec. 30, 2021) 416.66
Short % of Float (Dec. 30, 2021) 410.96%
Short % of Shares Outstanding (Dec. 30, 2021) 46.17%
Shares Short (prior month Nov. 29, 2021) 42.16M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec. 30, 2020
Most Recent Quarter (mrq)Sep. 29, 2021


Profit Margin 0.00%
Operating Margin (ttm)-1,043.74%

Management Effectiveness

Return on Assets (ttm)N/A
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)2.02M
Revenue Per Share (ttm)0.15
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -21.04M
Net Income Avi to Common (ttm)-20.91M
Diluted EPS (ttm)-1.56
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)387.51M
Total Cash Per Share (mrq)9.31
Total Debt (mrq)235k
Total Debt/Equity (mrq)0.06
Current Ratio (mrq)31.24
Book Value Per Share (mrq)9.05

Cash Flow Statement

Operating Cash Flow (ttm)-8.12M
Levered Free Cash Flow (ttm)N/A